Guardant Health Inc
(NAS:GH)
$
23.52
-0.08 (-0.34%)
Market Cap: 2.89 Bil
Enterprise Value: 3.22 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 69/100 Guardant Health Inc at Piper Sandler Healthcare Conference Transcript
Nov 28, 2023 / 02:30PM GMT
Release Date Price:
$24.79
(+1.60%)
David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
Thank you, everybody, for joining us. Today, we have Guardant Health, AmirAli, the Co-CEO; and Mike Bell, the CFO. Guardant Health probably doesn't need too much of an introduction, so maybe let's just dive into a little bit more about some of your innovation here.
Questions & Answers
David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
Can you talk about smart liquid biopsy, AI and the constant improvement of your assays that you're doing, starting from Guardant360, through the portfolio, the constant innovation and compound innovation, as you like to call it?
AmirAli Talasaz
Guardant Health, Inc. - Co-CEO & Director
Yes, sure. Hello, everybody. Good to be here. So as the tagline of the company says, conquer cancer with data. We are a company that has been focused on capturing data, high-quality data that would help with this mission of adding
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot